In 2021, we generated EUR 282 million in revenue, and our active custom projects pipeline included 196 projects at the end of the year. The structure of revenue and the active custom projects pipeline provide insights into our activities and the innovation efforts of our customers.
Helping patients across multiple diseases
Approx. revenue split by therapeutic areas (as per 31 December 2021)
Metabolic
Gastrologic
Oncologic
Cardio- and neurologic
Other
Servicing a diversified customer base
Approx. revenue split by customer type (as per 31 December 2021)
Large pharma
Biotech
Other pharma & academia
Solutions along the value chain
Revenue by business area (as per 31 December 2021)
Custom Projects
Contract Manufacturing
Generetic & Cosmetics
Solutions along the value chain
Number of active custom projects (as per 31 December 2021)
Pre-clinical
Phase I
Phase II
Phase III